0001279569-21-000727.txt : 20210528 0001279569-21-000727.hdr.sgml : 20210528 20210528150514 ACCESSION NUMBER: 0001279569-21-000727 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210528 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 4Front Ventures Corp. CENTRAL INDEX KEY: 0001783875 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56075 FILM NUMBER: 21979604 BUSINESS ADDRESS: STREET 1: 2900-550 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 BUSINESS PHONE: (602) 682-7037 MAIL ADDRESS: STREET 1: 2900-550 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 0A3 8-K 1 fourfront8k.htm FORM 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 28, 2021 (May 24, 2021)

 

 

 

4FRONT VENTURES CORP.

(Exact name of registrant as specified in its charter}

 

 

 

         
British Columbia   000-56075   83-4168417

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

5060 N. 40th Street, Suite 120

Phoenix, Arizona 85018

(Address of principal executive offices including zip code)

 

(602) 633-3067

(Registrant’s telephone number including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

         
Title of each class   Trading
Symbol		  

Name of exchange

on which registered

N/A        

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 
 
 

 

Item 5.02          Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

 

On May 24, 2021, Joshua Rosen provided notice of his resignation as a member of the board of directors (the “Board”) of the Company, and the Board accepted Mr. Rosen’s resignation effective as of the same date.  Mr. Rosen’s resignation was not in connection with any known disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. In connection with his resignation, the Compensation Committee of the Board agreed to extend the expiry date of Mr. Rosen’s outstanding options to purchase (i) 4,095 shares of the Company’s Subordinated Voting Shares (“SVS”) until September 16, 2024 at an exercise price of $8.00 per share, (ii) 25,000 SVS until August 22, 2024 at an exercise price of $80.00 per share, and (iii) 2,000,000 SVS until December 2, 2025 at an exercise price of $1.11 per share. The foregoing exercise prices assume a U.S. dollar/Canadian dollar exchange rate of 1.21 as of May 26, 2021.

 

Mr. Rosen served as the chairman of the Board. In order to fill the vacancy as Board chairman created by Mr. Rosen’s resignation, also on May 24, 2021, the Board appointed current Board member Kathi Lentzsch as chairperson of the Board.

 

 

 
 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

         
      4FRONT  VENTURES CORP.
     
Date: May 28, 2021       /s/ Leonid Gontmakher
        Leonid Gontmakher
        Chief Executive Officer